| Title: | Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations |
| Journal: | Genome Medicine |
| Published: | 10 Jan 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38200577/ |
| DOI: | https://doi.org/10.1186/s13073-023-01255-7 |
| URL: | https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-023-01255-7 |
| Citations: | 2 (2 in last 2 years) as of 8 Aug 2024 |
Publication 8965
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundType 2 diabetes (T2D) is a heterogeneous and polygenic disease. Previous studies have leveraged the highly polygenic and pleiotropic nature of T2D variants to partition the heterogeneity of T2D, in order to stratify patient risk and gain mechanistic insight. We expanded on these approaches by performing colocalization across GWAS traits while assessing the causality and directionality of genetic associations.MethodsWe applied colocalization between T2D and 20 related metabolic traits, across 243 loci, to obtain inferences of shared casual variants. Network-based unsupervised hierarchical clustering was performed on variant-trait associations. Partitioned polygenic risk scores (PRSs) were generated for each cluster using T2D summary statistics and validated in 21,742 individuals with T2D from 3 cohorts. Inferences of directionality and causality were obtained by applying Mendelian randomization Steiger's Z-test and further validated in a pediatric cohort without diabetes (aged 9-12 years old, n = 3866).ResultsWe identified 146 T2D loci that colocalized with at least one metabolic trait locus. T2D variants within these loci were grouped into 5 clusters. The clusters corresponded to the following pathways: obesity, lipodystrophic insulin resistance, liver and lipid metabolism, hepatic glucose metabolism, and beta-cell dysfunction. We observed heterogeneity in associations between PRSs and metabolic measures across clusters. For instance, the lipodystrophic insulin resistance (Beta − 0.08 SD, 95% CI [− 0.10-0.07], p = 6.50 × 10−32) and beta-cell dysfunction (Beta − 0.10 SD, 95% CI [− 0.12, − 0.08], p = 1.46 × 10−47) PRSs were associated to lower BMI. Mendelian randomization Steiger analysis indicated that increased T2D risk in these pathways was causally associated to lower BMI. However, the obesity PRS was conversely associated with increased BMI (Beta 0.08 SD, 95% CI 0.06-0.10, p = 8.0 × 10−33). Analyses within a pediatric cohort supported this finding. Additionally, the lipodystrophic insulin resistance PRS was associated with a higher odds of chronic kidney disease (OR 1.29, 95% CI 1.02-1.62, p = 0.03).ConclusionsWe successfully partitioned T2D genetic variants into phenotypic pathways using a colocalization first approach. Partitioned PRSs were associated to unique metabolic and clinical outcomes indicating successful partitioning of disease heterogeneity. Our work expands on previous approaches by providing stronger inferences of shared causal variants, causality, and directionality of GWAS variant-trait associations.</p>
11 Authors
- Samuel Ghatan
- Jeroen van Rooij
- Mandy van Hoek
- Cindy G. Boer
- Janine F. Felix
- Maryam Kavousi
- Vincent W. Jaddoe
- Eric J. G. Sijbrands
- Carolina Medina-Gomez
- Fernando Rivadeneira
- Ling Oei
1 Application
| Application ID | Title |
|---|---|
| 67864 | Polygenic risk score transportability across populations and complex traits: characterizing clinical applications of risk profiles within the context of the Genotyping Of ALL (GOALL) project |
Enabling scientific discoveries that improve human health